taking tirzepatide and retatrutide together or Tirzepatide? Triple vs Dual Agonist Guide Retatrutide vs Tirzepatide: Benefits and

Acknowledgements We thank the funding provided by the Malcolm W

Furthermore, candidates for GLP-1 may include: Individuals with obesity who have a body mass index (BMI) of 30 or higher or who have a BMI of 27 or higher and also have at least one weight-related health condition, such as type 2 diabetes or high blood pressure

Already, weve seen pushback from both health insurance companies (despite the fact that lowered obesity would lower claims, which they are supposed to like, but don't for obvious reasons - $$$)

However, adverse events, particularly nausea and digestive symptoms, were more common among participants taking GLP-1 drugs, and some stopped treatment due to side effects

The muscle loss on GLP-1 drugs is real

Temporary dialysis if severe